Literature DB >> 20967365

A tiered procedure for assessing the formation of biotransformation products of pharmaceuticals and biocides during activated sludge treatment.

Susanne Kern1, Rebekka Baumgartner, Damian E Helbling, Juliane Hollender, Heinz Singer, Martin J Loos, René P Schwarzenbach, Kathrin Fenner.   

Abstract

Upon partial degradation of polar organic micropollutants during activated sludge treatment, transformation products (TPs) may be formed that enter the aquatic environment in the treated effluent. However, TPs are rarely considered in prospective environmental risk assessments of wastewater-relevant compound classes such as pharmaceuticals and biocides. Here, we suggest and evaluate a tiered procedure, which includes a fast initial screening step based on high resolution tandem mass spectrometry (HR-MS/MS) and a subsequent confirmatory quantitative analysis, that should facilitate consideration of TPs formed during activated sludge treatment in the exposure assessment of micropollutants. At the first tier, potential biotransformation product structures of seven pharmaceuticals (atenolol, bezafibrate, ketoprofen, metoprolol, ranitidine, valsartan, and venlafaxine) and one biocide (carbendazim) were assembled using computer-based biotransformation pathway prediction and known human metabolites. These target structures were screened for in sludge-seeded batch reactors using HR-MS/MS. The 12 TPs found to form in the batch experiments were then searched for in the effluents of two full-scale, municipal wastewater treatment plants (WWTPs) to confirm the environmental representativeness of this first tier. At the second tier, experiments with the same sludge-seeded batch reactors were carried out to acquire kinetic data for major TPs that were then used as input parameters into a cascaded steady-state completely-stirred tank reactor (CSTR) model for predicting TP effluent concentrations. Predicted effluent concentrations of four parent compounds and their three major TPs were corroborated by comparison to 3-day average influent and secondary effluent mass flows from one municipal WWTP. CSTR model-predicted secondary effluent mass flows agreed within a factor of two with measured mass flows and confidence intervals of predicted and measured mass flows overlapped in all cases. The observed agreement suggests that the combination of batch-determined transformation kinetics with a simple WWTP model may be suitable for estimating aquatic exposure to TPs formed during activated sludge treatment. Overall, we recommend the tiered procedure as a realistic and cost-effective approach to include consideration of TPs of wastewater-relevant compounds into exposure assessment in the context of prospective chemical risk assessment.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20967365     DOI: 10.1039/c0em00238k

Source DB:  PubMed          Journal:  J Environ Monit        ISSN: 1464-0325


  12 in total

1.  Behavior of sartans (antihypertensive drugs) in wastewater treatment plants, their occurrence and risk for the aquatic environment.

Authors:  Anne Bayer; Robert Asner; Walter Schüssler; Willi Kopf; Klaus Weiß; Manfred Sengl; Marion Letzel
Journal:  Environ Sci Pollut Res Int       Date:  2014-06-06       Impact factor: 4.223

2.  Approach for detecting mutagenicity of biodegraded and ozonated pharmaceuticals, metabolites and transformation products from a drinking water perspective.

Authors:  Stefan Gartiser; Christoph Hafner; Kerstin Kronenberger-Schäfer; Oliver Happel; Christoph Trautwein; Klaus Kümmerer
Journal:  Environ Sci Pollut Res Int       Date:  2012-05-01       Impact factor: 4.223

3.  Removal and seasonal variability of selected analgesics/anti-inflammatory, anti-hypertensive/cardiovascular pharmaceuticals and UV filters in wastewater treatment plant.

Authors:  Oksana Golovko; Vimal Kumar; Ganna Fedorova; Tomas Randak; Roman Grabic
Journal:  Environ Sci Pollut Res Int       Date:  2014-03-07       Impact factor: 4.223

4.  The impact of different proportions of a treated effluent on the biotransformation of selected micro-contaminants in river water microcosms.

Authors:  Karsten Nödler; Maria Tsakiri; Tobias Licha
Journal:  Int J Environ Res Public Health       Date:  2014-10-10       Impact factor: 3.390

5.  Structural confirmation of sulconazole sulfoxide as the primary degradation product of sulconazole nitrate.

Authors:  Qun Xu; Ashraf Khan; Di Gao; Kristie M Adams; Fatkhulla Tadjimukhamedov; Shane Tan; John T Simpson
Journal:  J Pharm Anal       Date:  2017-12-19

6.  Bacterial Diversity Controls Transformation of Wastewater-Derived Organic Contaminants in River-Simulating Flumes.

Authors:  Malte Posselt; Jonas Mechelke; Cyrus Rutere; Claudia Coll; Anna Jaeger; Muhammad Raza; Karin Meinikmann; Stefan Krause; Anna Sobek; Jörg Lewandowski; Marcus A Horn; Juliane Hollender; Jonathan P Benskin
Journal:  Environ Sci Technol       Date:  2020-04-20       Impact factor: 9.028

7.  Transformation of organic micropollutants along hyporheic flow in bedforms of river-simulating flumes.

Authors:  Anna Jaeger; Malte Posselt; Jonas L Schaper; Andrea Betterle; Cyrus Rutere; Claudia Coll; Jonas Mechelke; Muhammad Raza; Karin Meinikmann; Andrea Portmann; Phillip J Blaen; Marcus A Horn; Stefan Krause; Jörg Lewandowski
Journal:  Sci Rep       Date:  2021-06-22       Impact factor: 4.379

8.  Biodegradability and transformation of human pharmaceutical active ingredients in environmentally relevant test systems.

Authors:  Silvia Berkner; Claudia Thierbach
Journal:  Environ Sci Pollut Res Int       Date:  2013-06-14       Impact factor: 4.223

9.  Evaluation of a Novel Approach for Reducing Emissions of Pharmaceuticals to the Environment.

Authors:  Thomas G Bean; Ed Bergstrom; Jane Thomas-Oates; Amy Wolff; Peter Bartl; Bob Eaton; Alistair B A Boxall
Journal:  Environ Manage       Date:  2016-06-24       Impact factor: 3.266

10.  Tracing the limits of organic micropollutant removal in biological wastewater treatment.

Authors:  Per Falås; Arne Wick; Sandro Castronovo; Jonathan Habermacher; Thomas A Ternes; Adriano Joss
Journal:  Water Res       Date:  2016-03-04       Impact factor: 11.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.